David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Crane NXT
CXT
$2.91B
| $2.51M | ﹤0.01% |
90,337
-73,798
| -45% | -$1.98M |
|
|
WOW
1827
DELISTED
WideOpenWest
WOW
| $2.51M | ﹤0.01% |
+166,273
| New | +$2.7M |
|
|
VRTV
1828
DELISTED
VERITIV CORPORATION
VRTV
| $2.51M | ﹤0.01% |
+77,144
| New | +$2.58M |
|
1829
Diamondrock Hospitality Co
DRH
$2.58B
| $2.5M | ﹤0.01% |
228,406
+22,659
| +11% | +$253K |
|
1830
AtriCure
ATRC
$2.45B
| $2.5M | ﹤0.01% |
111,683
+27,743
| +33% | +$627K |
|
1831
Thor Industries
THO
$4.05B
| $2.5M | ﹤0.01% |
19,834
-122,410
| -86% | -$13.2M |
|
1832
AngioDynamics
ANGO
$649M
| $2.5M | ﹤0.01% |
146,001
+77,354
| +113% | +$1.3M |
|
1833
SolarEdge
SEDG
$2.04B
| $2.5M | ﹤0.01% |
+87,395
| New | +$2.2M |
|
|
EGIO
1834
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.49M | ﹤0.01% |
15,677
-155
| -1% | -$21.8K |
|
|
MNK
1835
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $2.49M | ﹤0.01% |
66,600
+26,600
| +67% | +$1.06M |
|
1836
CALL
Raymond James Financial
RJF
$34B
| $2.49M | ﹤0.01% |
+44,250
| New | +$2.39M |
|
1837
GATX Corp
GATX
$6.3B
| $2.49M | ﹤0.01% |
40,401
+33,475
| +483% | +$2.06M |
|
|
MITL
1838
DELISTED
Mitel Networks Corporation
MITL
| $2.48M | ﹤0.01% |
295,376
-250,809
| -46% | -$1.99M |
|
|
CLVS
1839
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.47M | ﹤0.01% |
30,000
+10,000
| +50% | +$793K |
|
1840
PUT
Estee Lauder
EL
$38B
| $2.47M | ﹤0.01% |
22,900
+2,900
| +15% | +$298K |
|
1841
PUT
Affiliated Managers Group
AMG
$9.58B
| $2.47M | ﹤0.01% |
13,000
| – | – |
|
|
PRFT
1842
DELISTED
Perficient Inc
PRFT
| $2.47M | ﹤0.01% |
125,393
-22,843
| -15% | -$416K |
|
1843
PUT
Compass Minerals
CMP
$1.03B
| $2.46M | ﹤0.01% |
37,900
-2,000
| -5% | -$134K |
|
1844
News Corp Class B
NWS
$18.9B
| $2.46M | ﹤0.01% |
179,965
+68,510
| +61% | +$953K |
|
|
SODA
1845
DELISTED
SodaStream International Ltd
SODA
| $2.46M | ﹤0.01% |
+36,952
| New | +$2.15M |
|
1846
PUT
LendingTree
TREE
$418M
| $2.44M | ﹤0.01% |
10,000
| – | – |
|
1847
Atmos Energy
ATO
$28.6B
| $2.44M | ﹤0.01% |
29,115
-23,949
| -45% | -$2.07M |
|
|
ZPIN
1848
DELISTED
Zhaopin Limited
ZPIN
| $2.44M | ﹤0.01% |
133,962
-400
| -0.3% | -$7.4K |
|
|
AKS
1849
DELISTED
AK Steel Holding Corp
AKS
| $2.44M | ﹤0.01% |
435,764
+234,141
| +116% | +$1.34M |
|
1850
Quanex
NX
$910M
| $2.43M | ﹤0.01% |
105,973
-31,471
| -23% | -$651K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.